Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» CSL snags a preclinical stem cell therapy in $416M Calimmune buyout
CSL snags a preclinical stem cell therapy in $416M Calimmune buyout
CSL snags a preclinical stem cell therapy in $416M Calimmune buyout
Submitted by
admin
on August 28, 2017 - 9:29am
Source:
Endpoints
News Tags:
CSL
Calimmune
M&A
stem cells
Headline:
CSL snags a preclinical stem cell therapy in $416M Calimmune buyout
Do Not Allow Advertisers to Use My Personal information
